DoxyPEP has revolutionised STI prevention but 2025 data reveals a hidden cost regarding antibiotic resistance. A major review highlights rising resistance in Gonorrhoea which suggests that we must refine who uses these protocols and how we test for infections to preserve our critical medical defences.

A major 2025 study reveals a syndemic where Syphilis and Hepatitis C intersect with the opioid crisis to create severe risks during pregnancy. This deep dive narrative explores how these epidemics interact and explains why integrated screening for couples is the most logical step to protect future generations.

Research highlights a challenge for male cancer survivors where chemotherapy may leave invisible marks on sperm DNA even after counts return to normal. These molecular changes are linked to recurrent miscarriage which suggests that sperm banking before treatment is an essential step for future family planning.

A landmark 2025 study has reclassified Bacterial Vaginosis from a simple imbalance to a sexually transmitted infection. Researchers identified the male penile microbiome as a reservoir for recurrence which challenges decades of female-only treatment protocols. This discovery paves the way for new strategies involving partner treatment at your local std clinic.

The fight against drug-resistant STIs requires speed. New CRISPR-based diagnostics validated in 2025 can detect Gonorrhea and specific antibiotic resistance mutations in just 40 minutes. This technology allows doctors at your local std clinic to prescribe the exact drug needed while the patient is still in the consulting room.

Syphilis cases are rising globally but a 2025 breakthrough brings hope for a vaccine. New research identifies how the bacteria invades tissues and proves that a DNA vaccine can prevent the infection from spreading to organs. These findings could transform long-term prevention strategies at your local std clinic.

A 2025 study proposes a radical shift in Chlamydia prevention: oral vaccines. By utilizing the gut as an immunological training ground, researchers have successfully protected the genital tract in animal models. This gut-genital axis approach could revolutionize preventative care strategies at your std clinic.

New research in 2025 challenges the belief that herpes is incurable. Scientists at Fred Hutch have used gene editing to eliminate over 90% of latent virus in preclinical models , while a new long-acting drug offers a functional cure by blocking viral shedding. These advances promise to transform management at your local std clinic.

A future monthly PrEP pill highlights a current reality in Singapore: PrEP is not subsidised and is expensive. This contrasts with Taiwan’s successful government-funded program that lowered HIV rates. This policy gap means individuals must seek expert guidance to navigate their HIV prevention options effectively and affordably today.

A future monthly PrEP pill highlights a current reality in Singapore: PrEP is not subsidised and is expensive. This contrasts with Taiwan’s successful government-funded program that lowered HIV rates. This policy gap means individuals must seek expert guidance to navigate their HIV prevention options effectively and affordably today.